vendredi 23 février 2018

Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.

Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.

from NYT > Health http://ift.tt/2opx8DA
via health&fitness

Aucun commentaire:

Enregistrer un commentaire